Loading company…
Shanghai Bocimed provides R&D and manufacturing for drug delivery formulations and active pharmaceutical ingredients.
Based in Shanghai, China and established in 2012, Shanghai Bocimed Pharmaceutical Co., Ltd. focuses on drug delivery technology, providing R&D and production for complex and solubilization preparations, drug intermediates and active pharmaceutical ingredients. The company acquired the clinical CRO Chengdu Runze Pharmaceutical Technology Development Co., Ltd. in 2016. It plans to use funds raised in February 2023 for clinical development of new drugs including BCM335, BCM331, BCM291, BCM332, BCM345 and BCM347.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in